期刊
DERMATOLOGY PRACTICAL & CONCEPTUAL
卷 13, 期 1, 页码 -出版社
MATTIOLI 1885
DOI: 10.5826/dpc.1301a17
关键词
alopecia areata; ischemia-modified albumin; IMA; albumin; disease severity
类别
This study investigates the role of ischemia-modified albumin (IMA) and IMA/albumin levels in patients with AA. The results show significant differences in the mean values of IMA and IMA/albumin ratio between the study and control groups. However, these findings suggest that IMA and IMA/albumin may not be useful in predicting the severity of AA in patients.
Introduction: Objective: To investigate the role of ischemia-modified albumin (IMA) and IMA/albumin levels in patients with AA. Methods: The present prospective crossectional study includes patients & GE;18 who were admitted to the Dermatology and Venerology Department of Hitit University Hospital between April 1, 2021, and September 30, 2021. 70 patients participated in the study (n=34 for the study group and n=36 for the control group). Demographic features, clinical characteristics, IMA, and IMA/albumin levels were compared between the groups. The study group was divided into subgroups based on the number of patches, disease duration, and the number of disease attacks. IMA and IMA/albumin levels were compared between each subgroup. Results: The study and control groups were similar with regard to demographic features and clinical characteristics. Significant differences were observed between the mean IMA and IMA/albumin ratio (p=0.004 and 0.012, respectively). The study subgroups were comparable in the number of patches, disease duration, and number of disease attacks. Conclusion: Although oxidative stress is an important component in the etiology of AA, IMA and IMA/albumin may not be useful in the prediction of disease severity in patients with AA.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据